Beacon CARE Fertility has appointed Dr Israel Carmona as a Consultant, as it continues to expand its clinic team to meet increasing demand. Dr Carmona brings a wealth of experience to his new role, having worked in infertility for over 11 years, with experience in Mexico, the USA, Spain and now Ireland.
His interests are in the field of PCOS, recurrent miscarriage and implantation failure.
Dr Carmona’s sub-speciality training in Human Reproduction was carried out with the team that achieved the first IVF pregnancy in Mexico and he reinforced his knowledge with a fellowship in Texas, USA. In Spain he completed a Master’s Degree at the European Gynaecology Endoscopy School in Valencia and is a Professor of Infertility in Spain. Currently, he is doing a PhD in PCOS at the Catholic University of Murcia, Spain.
He is a Member of the European Society of Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM), both leading authorities in human reproduction. Dr Carmona is also an executive member of the Irish Fertility Society.
Speaking about his new role Dr Israel Carmona, Consultant, Beacon CARE Fertility said: “I’m delighted to join Beacon CARE Fertility, which is at the cutting edge of fertility treatments. My goals are to constantly improve the research and knowledge surrounding infertility and to offer world-class fertility care with a patient-centred approach. Beacon CARE Fertility is the perfect clinic in which to achieve these goals in Ireland – the expertise and state-of-the-art technology available here continues to produce excellent results.”
Beacon CARE Fertility is owned and operated by leading Irish healthcare company Beacon Medical Group and the renowned CARE Fertility, which has pioneered ground-breaking IVF therapies and embryo viability screening since 1997.
There have been over 30,000 CARE babies born to date.
Patients in Ireland can access the very latest international techniques in all aspects of fertility including fertility assessments, IVF, IUI, autoimmune therapies, egg and sperm freezing (vitrification), PGS using the very latest technology of Next Generation Sequencing for embryo viability screening, recurrent miscarriage therapies and PGD.